Skip to main content
RNTX filings

Corporate insider profile

James Brian Windsor Filing Activity

Latest reported as See Remarks of Rein Therapeutics, Inc. (RNTX).

Purchase filings
1
Reported companies
1
Net open-market value
$25,000
Latest transaction
Apr 30, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 30, 2026Rein Therapeutics, Inc. (RNTX)See RemarksOpen Market Purchase25,000$1.00$25,000